The Lancet publishes new data demonstrating superior efficacy of Victoza(R) (liraglutide [rDNA] injection) compared to Januvia(R) (sitagliptin) in the treatment of type ... ( PRINCETON N.J. About the study ...)

HOME >> MEDICINE >> TECHNOLOGY

The Lancet publishes new data demonstrating superior efficacy of Victoza(R) (liraglutide [rDNA] injection) compared to Januvia(R) (sitagliptin) in the treatment of type 2 diabetes

Date:4/23/2010

PRINCETON, N.J., April 23 /PRNewswire-FirstCall/ -- Yesterday, The Lancet published online the results of the first study comparing the once-daily human GLP-1 analog, Victoza® (liraglutide [rDNA] injection) with a DPP-4 inhibitor, Januvia®. The 26-week trial showed that Victoza® produced significantly greater reductions in A1C, fasting plasma glucose (FPG), and body weight than Januvia®, with similar or better overall treatment satisfaction.

In addition, significantly more patients achieved the A1C targets of <7.0% (American Diabetes Association [ADA]). Nearly twice as many study participants on Victoza® reached the ADA goal compared to the Januvia® group (56% and 44% in the 1.8mg and 1.2mg Victoza® groups versus 22% in the Januvia® group).

"These data clearly show that Victoza® at both doses was more effective than Januvia® at achieving blood sugar control in people with type 2 diabetes with the benefit of weight loss," said Dr. Richard Pratley, of the Diabetes and Metabolism Translational Medicine Unit, University of Vermont College of Medicine, Burlington. "With so many patients still struggling to lower their blood sugar, Victoza® represents an effective new option."

About the study

The study was a 26-week, randomized, parallel-group, open-label trial comparing safety and efficacy of the two recommended doses of once-daily Victoza® (1.2mg and 1.8mg) with once-daily Januvia® (100mg), all added to metformin. It was conducted in Europe and North America in 665 people with type 2 diabetes who we
'/>"/>

SOURCE Novo Nordisk
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6
Related medicine technology :

1. Landmark Study in The Lancet Oncology Shows Capecitabine (Xeloda(R)) Combination Therapy Reduces Early Breast Cancer Recurrence
2. Four Studies Published in The Lancet Show roflumilast (Daxas(R)), a New Oral Approach to COPD, Improves Lung Function and Reduces Exacerbations
3. Landmark Study for GSKs Cervical Cancer Vaccine Published in The Lancet
4. The Lancet Publishes Direct Comparison Study Between Liraglutide and Exenatide
5. The Lancet Publishes Two-Year Results of Abbotts Fully Bioabsorbable Drug Eluting Stent
6. NeurogesX Announces Publication of Phase 3 Data for QUTENZA(TM) (NGX-4010) in Postherpetic Neuralgia (PHN) by The Lancet Neurology
7. Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet
8. Data from One-Year Liraglutide Phase 3 Study Published Online in The Lancet
9. TRANSCEND(TM) Trial Results Presented at European Society of Cardiology Congress and Published in The Lancet
10. Medivation Announces Publication in The Lancet of Dimebon Pivotal Trial Results in Alzheimers Disease
11. Pivotal Pulmonary Arterial Hypertension Study Published in The Lancet Concludes That Bosentan (Tracleer(R)) Demonstrates Benefits in Patients With Mildly Symptomatic WHO Functional Class II Disease

Post Your Comments:

(Date:5/22/2013)... 22, 2013 The new 13-valent pneumococcal conjugate ... previous version used prior to 2010, the 7-valent pneumococcal ... published today in Vaccine. The U.S. Food ... 2010 after a series of trials. These trials found ... pneumococcal types than the previously used PCV7, did not ...

(Date:5/22/2013)... May 22, 2013 Healthcare providers are ... content management (ECM) solution, for a ... System . These organizations identified enterprise content ... will use OnBase to optimize their Meditech ... (Logo: http://photos.prnewswire.com/prnh/20090130/65710LOGO ) ...

(Date:5/22/2013)... , 22. Mai 2013 Kepner-Tregoe ... Beratung, gab heute bekannt, dass der Veteran ... , zum Hauptgeschäftsführer ernannt wurde. Geraghty,s ... Industriebereich wo er zahlreiche Führungspositionen bei Fertigungsunternehmen ... Baxter an, der als Kepner-Tregoe Hauptgeschäftsführer gedient ...

Breaking Medicine Technology:Kaiser Permanente Study Finds New Pneumococcal Vaccine Appears to be as Safe as Previously Used Vaccine 2 Kaiser Permanente Study Finds New Pneumococcal Vaccine Appears to be as Safe as Previously Used Vaccine 3 Kaiser Permanente Study Finds New Pneumococcal Vaccine Appears to be as Safe as Previously Used Vaccine 4 Three New Health Systems Integrate Hyland Software's OnBase with Meditech Hospital Information System 2 Three New Health Systems Integrate Hyland Software's OnBase with Meditech Hospital Information System 3 Kepner-Tregoe, Inc. befördert Chris Geraghty zum Hauptgeschäftsführer 2 Kepner-Tregoe, Inc. befördert Chris Geraghty zum Hauptgeschäftsführer 3

[0] Kaiser Permanente Study Finds New Pneumococcal Vaccine Appears to be as Safe as Previously Used Vaccine [0] Three New Health Systems Integrate Hyland Software's OnBase with Meditech Hospital Information System [0] Kepner-Tregoe, Inc. befördert Chris Geraghty zum Hauptgeschäftsführer

... , NEW YORK, Dec. 8 ... already $232 billion, and it is projected to grow 11 percent annually, ... entitled The Science of Personalized Medicine: Translating the Promise into Practice ... personal and genetic variation , is creating a booming market, but ...

... , INDIANAPOLIS, Dec. 7 Roche Diagnostics ... center in Pleasanton, California, as part of an initiative to ... and independent laboratories on the west and east coasts. Roche ... and is planning to open an additional facility in New ...

Cached Medicine Technology:$232 Billion Personalized Medicine Market to Grow 11 Percent Annually, says PricewaterhouseCoopers 2 $232 Billion Personalized Medicine Market to Grow 11 Percent Annually, says PricewaterhouseCoopers 3 $232 Billion Personalized Medicine Market to Grow 11 Percent Annually, says PricewaterhouseCoopers 4 $232 Billion Personalized Medicine Market to Grow 11 Percent Annually, says PricewaterhouseCoopers 5 $232 Billion Personalized Medicine Market to Grow 11 Percent Annually, says PricewaterhouseCoopers 6 Roche Diagnostics Opens State-of-the-Art Training Center in California 2

$232 Billion Personalized Medicine Market to Grow 11 Percent Annually, says PricewaterhouseCoopers Roche Diagnostics Opens State-of-the-Art Training Center in California

(Date:5/22/2013)... May 22, 2013 DePuy Pinnacle ... DePuy Pinnacle Hip Replacement System continue to move forward ... Bernstein Liebhard LLP reports. According to an Order ... to produce monitoring reports associated with a 2007 criminal ... device marketing practices. Plaintiffs maintained in their ...

(Date:5/22/2013)... 22, 2013 Today, Zane Benefits, Inc. ... Insurance Exchange . Zane Benefits, which provides comprehensive and ... the leader in defined contribution plans and ... Benefits’ website, beginning in 2014 as part of the ... and small businesses will become available through new state ...

(Date:5/22/2013)... that hospitals may be reaping enormous income for ... bloodstream infections contracted in their intensive care units. ... in the American Journal of Medical Quality ... who develops an avoidable central line-associated bloodstream infection ... for than a similar infection-free patient. Moreover, hospitals ...

(Date:5/22/2013)... 2013 Registered Dietitian and Founder of Tatalou ... Tatalou.com sharing a recipe for making energy bars at home. ... Bars ,” takes a recipe modified from one recently ... “Every day it gets more and more difficult to understand ... “The size of the nutrition label continues to grow and ...

(Date:5/22/2013)... (PRWEB) May 22, 2013 Unknown to the ... area at 30 mph. Minutes before it struck, the ... the nearing threat. This gave them time to reach safety ... Data is proud to provide a product that will ... A Wheelock SAFEPATH® SP40S Emergency Evacuation System provides ...

Breaking Medicine News(10 mins):Health News:DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Notes New Order in Federal Pinnacle Litigation Requiring Production of Monitoring Reports from Federal Investigation 2 Health News:DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Notes New Order in Federal Pinnacle Litigation Requiring Production of Monitoring Reports from Federal Investigation 3 Health News:Zane Benefits Publishes New Information on Alabama Health Insurance Exchange 2 Health News:Zane Benefits Publishes New Information on Alabama Health Insurance Exchange 3 Health News:Hospitals profit when patients develop bloodstream infections 2 Health News:Hospitals profit when patients develop bloodstream infections 3 Health News:Hospitals profit when patients develop bloodstream infections 4 Health News:How To "Make Your Own Healthy Energy Bars" 2 Health News:Telcom & Data Introduces Wheelock SAFEPATH® SP40S Emergency Evacuation System, An Effective Office Tool to Protect Employees from Severe Weather Threats 2

[0] DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Notes New Order in Federal Pinnacle Litigation Requiring Production of Monitoring Reports from Federal Investigation [0] Zane Benefits Publishes New Information on Alabama Health Insurance Exchange [0] Hospitals profit when patients develop bloodstream infections [0] How To "Make Your Own Healthy Energy Bars"[0] Telcom & Data Introduces Wheelock SAFEPATH® SP40S Emergency Evacuation System, An Effective Office Tool to Protect Employees from Severe Weather Threats

... Feb. 20 /Xinhua-PRNewswire/ -- Venture Global Limited,unveils the ... pollution. With VEGO Power Blocker, cellphone users could ... Be Protected, VEGO Power Blocker Kills the Invisible ... VEGO Power Blocker is a piece of ultra-thinned ...

... first scientific evidence that deadly emerging diseases have ... the outbreaks main sources. They say new diseases ... the greatest threat to humans. Expansion of humans ... with wildlife are the reason, they say. Meanwhile, ...

... Anti-bleeding agent Trasylol tied to increased death, complications, studies ... new studies confirm an increased incidence of death and ... used to reduce bleeding during coronary artery bypass surgeries. ... over both the short- and long-term. , Trasylol,s German ...

... , , WEDNESDAY, Feb. 20 (HealthDay News) -- The time of day ... the difference between life and death. , Two new studies find ... weekends are more likely to die in the hospital than those ... acceptable, one researcher said. "We should not be treating patients ...

... heart disease had no ... risk factors, BALTIMORE, Feb. 20 In an effort to ... Foundation will,hold its annual Women,s Heart Health Fair on Tues., Feb. ... Mayor Sheila,Dixon has granted non-essential female workers two hours leave that ...

... put an end to toothaches, PHILADELPHIA, Feb. ... model, based in Philadelphia, announced that it is,expanding ... offering licensing,opportunities to qualifying dental practices, worldwide. This ... in advancing,affordable dental/health care available everywhere, to all., ...

Cached Medicine News:Health News:Venture Global Limited Introduces an Innovative Anti-Cellphone Radiation Sticker Named 'VEGO Power Blocker' 2 Health News:Scientists make first map of emerging-disease hotpsots 2 Health News:Scientists make first map of emerging-disease hotpsots 3 Health News:More Evidence of Danger From Heart Surgery Drug 2 Health News:More Evidence of Danger From Heart Surgery Drug 3 Health News:In-Hospital Stroke Deaths Rise on Nights, Weekends 2 Health News:In-Hospital Stroke Deaths Rise on Nights, Weekends 3 Health News:Free Health Screenings Aim to Identify Risk of Heart Disease in Women 2 Health News:Emergency Dentist 24/7(TM) Announces Worldwide Licensing Program 2

Venture Global Limited Introduces an Innovative Anti-Cellphone Radiation Sticker Named 'VEGO Power Blocker'Scientists make first map of emerging-disease hotpsots More Evidence of Danger From Heart Surgery Drug In-Hospital Stroke Deaths Rise on Nights, Weekends Free Health Screenings Aim to Identify Risk of Heart Disease in Women Emergency Dentist 24/7(TM) Announces Worldwide Licensing Program

Stat Detection of Soluble Fibrin Monomer Complexes by the Hemagglutination Technique, 32 tests....

For use with catalog #0540....

Immuno-turbidimetric Assay of D-Dimer by STA© Analyzers. Microlatex particles coated with two different mouse monoclonal anti-human D-Dimer antibodies....

Antigenic Free Protein S, ELISA Method...

Medicine Products:

FS TEST UNIT FDP PLASMA LATEX STA LIATEST D-DI ASSERACHROM FREE PROTEIN S